(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis. by Long Li (6555)

National age-standardized rates of DALYs and ASDR of IHD attributable to HSBP and their estimated annual percentage changes in 2021. by Zhenhua Zhuang (11192745)

Age-specific estimated annual percentage changes in DALYs and death rates for 21 regions from 1990 to 2021. by Zhenhua Zhuang (11192745)

Mean confidence in public health organizations among US adults. by Hannah Melchinger (20234665)

Subjects:

Percentage of US adults reporting high confidence in public health organizations. by Hannah Melchinger (20234665)

Subjects:

Changes in AL (A) and SE (B) according to the treatment time estimation curve in patients given 0.125% atropine. by Zi-Rong Chen (9227618)

Subjects:

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

Modeling the Shape and Stability of Co Nanoparticles as a Function of Size and Support Interactions through DFT Calculations and Monte Carlo Simulations by Enrico Sireci (12127349)

“…We report a marked increase in step and kink sites at the expense of terraces with increasing particle size, which we linked to the experimentally observed increase in turnover frequency (TOF). …”

Age-standardized incidence rates by sex, for (A) hepatitis B virus-attributable hepatocellular carcinoma; (B) hepatitis C virus-attributable hepatocellular carcinoma—Surveillance,... by Joy Jiang (5483006)

Subjects:

Prevalence of infection with (A) hepatitis B virus or (B) hepatitis C virus hepatocellular carcinoma among Medicare Part D beneficiaries, 2007–2017. by Joy Jiang (5483006)

Subjects:

Age-standardized hepatocellular carcinoma (HCC) incidence rates, by viral hepatitis status, the surveillance, epidemiology, and end results–medicare database, 2007–2017. by Joy Jiang (5483006)

Subjects:

Incidence of (A) hepatitis B virus (HBV)-attributable hepatocellular carcinoma (HCC) and (B) hepatitis C virus (HCV)-attributable HCC in the SEER-Medicare population and frequency... by Joy Jiang (5483006)

Subjects:

Group-level narrow- and broad-band spectral changes after hemispherotomy reveal a marked EEG slowing of the isolated cortex, robust across patients. by Michele Angelo Colombo (22446342)

“…This decrease was larger in the disconnected than in the contralateral cortex. …”

Table 2 - Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study by Zi-Rong Chen (9227618)

Subjects:

Age-standardized hepatocellular carcinoma incidence rates among patients without viral hepatitis, by status for diabetes and/or obesity, alcohol-related liver disorders and rare ge... by Joy Jiang (5483006)

Subjects:

Projected global leukemia burden, 1990-2050. by Chengjun Hu (588206)

“…Methods: From 1990 to 2021, we analyzed age-standardized rates (ASR) trends across 204 countries and territories, utilizing the estimated annual percentage change (EAPC). …”

Correlation between HDI and EAPC. by Chengjun Hu (588206)

“…Methods: From 1990 to 2021, we analyzed age-standardized rates (ASR) trends across 204 countries and territories, utilizing the estimated annual percentage change (EAPC). …”

Global leukemia incidence and EAPC, 1990-2021. by Chengjun Hu (588206)

“…Methods: From 1990 to 2021, we analyzed age-standardized rates (ASR) trends across 204 countries and territories, utilizing the estimated annual percentage change (EAPC). …”

Average annual percent change (AAPC) with 95% confidence interval (CI) in age standardized hepatocellular carcinoma incidence rates per 100,000, overall and by hepatitis B virus (H... by Joy Jiang (5483006)

Subjects:

Characteristics of individuals with hepatocellular carcinoma, by hepatitis B virus (HBV) and hepatitis C virus (HCV) infection status, SEER-Medicare, 2007–2017. by Joy Jiang (5483006)

Subjects: